Abstract Non-deletional α + -thalassaemia is associated with a higher degree of morbidity and mortality than deletional forms of α + -thalassaemia. Screening for the common deletional forms of α-thalassaemia by Gap-PCR is widely practiced; however, the detection of nondeletional α-thalassaemia mutations is technically more labour-intensive and expensive, as it requires DNA sequencing. In addition, the presence of four very closely homologous alpha globin genes and the frequent coexistence of deletional forms of α-thalassaemia present another layer of complexity in the detection of these mutations. With growing evidence that non-deletional α-thalassaemia is relatively common in the UK, there is a demand for technologies which can quickly and accurately screen for these mutations. We describe a method utilising pyrosequencing for detecting the ten most common clinically significant non-deletional α-thalassaemia mutations in the UK. We tested 105 patients with non-deletional α-thalassaemia and found 100% concordance with known genotype as identified by Sanger sequencing. We found pyrosequencing to be simpler, more robust, quicker, and cheaper than conventional sequencing, making it a good choice for rapid and cost-effective diagnosis of patients with suspected non-deletional α-thalassaemia. The technique is also likely to help expedite prenatal diagnosis of pregnancies at risk of α-thalassaemia major.
Introduction α-Thalassaemia is the most common monogenic disorder in the world [1, 2] . It results from reduced or absent synthesis of alpha-globin from one or both of the two alpha-globin genes on chromosome 16 . It is a heterogeneous condition ranging from asymptomatic carrier states to the lethal condition of Hb Bart's hydrops fetalis which results when an individual is homozygous for a deletion which removes both alpha globin genes. Haemoglobin H disease is the most clinically severe form of α-thalassaemia compatible with life, characterised by reduced synthesis of α-globin from three of the four α-globin genes. This results in the accumulation of β-globin tetramers (Hb H) which are relatively unstable, causing haemolytic anaemia, Hb H also has a high oxygen affinity which results in tissue hypoxia. The pathophysiology of Hb H disease is complex and can vary widely, even in patients with identical α-globin genotypes [3] [4] [5] . Most cases of Hb H disease are caused by α-globin gene deletions [6] ; however, patients with non-deletional Hb H disease usually have more severe phenotypes and are more likely to require trans-fusions, some mutations can even result in the lethal form of Hb H disease known as Hb H hydrops fetalis [3] . Mutations in the α2 globin gene are usually more severe than mutations in the α1-globin gene as more globin is produced from the α2 gene than from the α1 gene [7] .
In the UK, it is becoming evident that non-deletional α-thalassaemia mutations are found in a wider spectrum of the population than previously thought, with the discovery of 30 different mutations out of the known published worldwide total of 67 non-deletion mutations (46%) [8] . This gives the UK the widest range of α-thalassaemia mutations of any country with a published spectrum of mutations. Couples at risk of having a fetus affected by Hb H hydrops fetalis and requesting prenatal diagnosis have also been identified in the UK [9] . There are ten non-deletional α-thalassaemia mutations that are clinically significant and relatively common within the UK population [8] . These mutations consist of the α2 termination codon mutations (Hb Constant Spring, Hb Paksé, Hb Icaria, and Hb Seal Rock), the α2 polyadenylation signal mutations (Saudi, Turkish, and Indian Mutations), and the mutations which give rise to the hyper-unstable alpha globin chain variants Sun Prairie, Quong Sze, and Adana (Table 1) .
There is therefore a need for a quick and inexpensive method to detect these mutations. Also, the inception of the UK National Sickle Cell and Thalassaemia Screening Program in 2001 [10, 11] has driven the development of faster and more accurate technologies. Unlike the common deletional α-thalassaemia mutations which can be identified by simple and inexpensive techniques such as Gap-PCR, nondeletional mutations usually require identification by DNA sequencing which is more expensive and labour-intensive.
Pyrosequencing is a real-time sequencing technique based on the detection of light [12, 13] . It is rapid and inexpensive and has been used for the detection of a number of genetic disorders, including the assessment of disease burden in myeloproliferative disorders [14] [15] [16] . These reports have demonstrated the flexibility and accuracy of the technique; however, these reports have focused on single copy genes. The α-globin genes can be challenging to study as the two genes are highly homologous and reside in a GC-rich cluster with other highly homologous genes making specific gene amplification problematic. An added difficulty is the extremely high population frequency of the deletional forms of α-thalassaemia [17] . This means that it is not unusual for individuals to have co-existing deletional and non-deletional α-thalassaemia mutations which can make data interpretation complex. Against these technical difficulties, we will investigate whether pyrosequencing can be used as a rapid screening method to accurately distinguish the ten most common clinically significant mutations in the α1 and α2 globin genes.
Materials and method
Genomic DNA samples from 105 patients who had previously been identified as having non-deletion α + -thalassaemia (by Sanger sequencing) were used in the study. Co-existing deletional α-thalassaemia mutations were detected by Gap-PCR [18] or MLPA [19] . DNA was extracted from 1 ml of whole blood in EDTA using Chemagic Magnetic Separation module 1 or by standard phenol-chloroform procedures. Three pyrosequencing assays were designed to screen for the -thalassaemia a can result in Hb H hydrops fetalis [6, 9] ten most common clinically significant non-deletional mutations within the α2-and α1-globin genes. Amplification of the polyadenylation and termination codon mutation site was performed using a PCR primer pair specific for the α2 gene. Two separate sequencing primers where then used in the pyrosequencing reaction (one to identify the polyadenylation mutations and the other to identify the termination codon mutations). The mutations for the haemoglobin variants Quong Sze and Sun Prairie in the α2 gene were amplified using a second set of primers and identified by the same sequencing primer as the mutations are only 16 bp apart. The sequencing primer was anti-sense and located one base pair downstream from the mutation site for Hb Sun Prairie. Dispensation of 17 nucleotides was programmed, covering 25 base pairs. The haemoglobin Adana mutation in exon 2 was amplified in a third PCR reaction. Due to the sequence homology of the α-globin genes and fragment size limitations of pyrosequencing, amplification primers could not be designed which were specific to the α1 or the α2 gene. Pyrosequencing for Hb Adana would therefore detect mutations on both the α2 and α1 genes. Sequencing was performed in a reverse (anti-sense) direction. Primer sequences for all reactions are provided in Table 2 .
Each 25 μl PCR reaction contained 2× Qiagen Multiplex Mastermix, 10× Q-Solution and 10 μM each primer. All PCR conditions consisted of an initial hotstart denaturation at 94°C for 15 min, 40 cycles of 94°C for 30 sec, 65°C for 1½ min, 72 for 1½ minute; and final extension at 72°C for 10 min. Prior to pyrosequencing, 5 μl of PCR product underwent electrophoresis on an agarose gel to confirm successful amplification. The PCR products (20 μl) were then sequenced by Pyromark Q24 System (Qiagen) following manufacturers instructions. Briefly, a bead mix containing 2 μl of Streptavadin sepharose beads (Amersham Biosciences), 18 μl of molecular-grade water (Sigma) and 40 μl of Binding Buffer (Qiagen) was mixed with the PCR product for 5 min on a plate shaker in order to retain the biotinylated PCR product onto the sepharose beads. The immobilised PCR products were captured onto the filter probes on the Prep Tool by applying a vacuum and washed in 70% ethanol for 5 s, denaturation solution (Qiagen) for 5 s, and 1× Wash Buffer (Qiagen) for 10 s. The vacuum was then switched off, and the singlestranded PCR products released onto a Pyromark Q24 Plate (Qiagen) containing 25 μl Annealing Buffer (Qiagen) and 0.8 μl of sequencing primer (10 μM). The sequencing plate was heated for 2 min at 80°C and allowed to cool at room temperature for 5 min to allow annealing of the sequencing primer. Sequencing was performed using programmed dispensation of nucleotides. The nucleotide dispensation order was designed to give the clearest and most unambiguous sequencing pattern. The pyrogram sequence pattern was interpreted by PyroMark Q24 software (Qiagen).
Results

Identification of polyadenylation and termination codon mutations
Pyrosequencing was 100% concordant with expected genotype as confirmed by Sanger sequencing, unequivocally identifying all heterozygotes, hemizygotes and homozygotes. (Table 3 , Fig. 1 ). Pyrosequencing is semi-quantitative as the detection of light is equal in molarity to the number of incorporated nucleotides; it therefore offers the advantage of providing allelic ratios at the target site of interest. Theoretically the ratio of wild-type to mutant allele detected in heterozygotes should be 1:1; however, we found that the ratios detected varied considerably depending on the mutation, and this was particularly evident with polyadenylation signal mutations. This is probably because the polyadenylation signal has a homopolymeric run of three A nucleotides (ATAAA). The light emission from a run of the same nucleotides is non-linear which means the resulting allelic Table 2 Primer sequences and nucleotide dispensation order used in pyrosequencing assays ratio will be skewed. However, the software is mostly able to compensate to for this, as peak heights are still largely proportional to the number of incorporated nucleotides, allowing unequivocal determination of the sequence. This effect was also evident in the identification of heterozygotes for the termination codon mutation Hb Icaria, which was more difficult to resolve as the mutation also forms part of a homopolymeric repeat. However, the reduction in the normal allele and visual comparison of the pyrogram against normal patient samples made manual interpretation of the pyrogram unambiguous. Another factor was that the supplied Pyromark software was unable to score the Indian polyadenylation signal 2 bp deletion mutation (ATA-); this is because the software cannot calculate the out-of-phase signal generated by a deletion. In spite of this technical limitation, visual examination of the pyrogram clearly showed that peak heights are still largely proportional to the number of incorporated nucleotides, allowing for unequivocal identification of the deletion when compared to wild-type samples.
Identification of unstable alpha haemoglobin variant mutations
Pyrosequencing results were 100% concordant with conventional sequencing results ( Table 3 ). The allelic ratio for Hb Sun Prairie heterozygotes were marginally closer to the expected ratio of 1:1 than those obtained for Hb Quong Sze. This variation may be because of the longer read lengths employed in this assay. The read length was longer (25 bp) to allow the Hb Sun Prairie and Hb Quong Sze mutations to be identified in the same sequencing reaction. However, it is known that due to a reduction in enzyme efficiency and the build up of enzyme inhibitors the quality of the sequence in a pyrosequencing reaction diminishes with increasing length [20] . This probably explains why the allelic ratio observed in Quong Sze heterozygotes (which is downstream of the Sun Prairie mutation) is more variable than that observed in Sun Prairie heterozygotes. However, the quality of the sequencing at the Quong Sze mutation site was good enough to allow the mutation to be easily identified in all samples. Due to technical constraints (see Methods), the amplification primers designed to detect the Hb Adana mutation amplify both the α1 and α2 genes (Fig. 2) . This means that, unlike the other pyrosequencing reactions which only amplify the α2 gene, the expected allelic ratio between the mutant and wild-type allele is 1:3 for heterozygotes, 1:1 for homozygote's, and 1:1 or 1:2 for hemizygotes (depending on whether it is a one-gene or two-gene α-globin gene deletion on the other allele). Four of the samples that were tested for Hb Adana were amniotic fluid samples that had been referred for prenatal diagnosis from two separate couples at risk of a pregnancy affected with Hb H hydrops fetalis. Both mothers had α 0 -thalassaemia trait (-FIL /αα) whilst both fathers were carriers of Hb Adana. Pyrosequencing confirmed that all foetuses were compound heterozygous for both mutations and thus affected with Hb H hydrops fetalis.
Mutation detection by allelic ratios
The quantitative information providing by pyrosequencing unexpectedly resulted in the identification of a further mutation that would not have been detected by conventional sequencing. Two samples which were correctly identified as carriers of the Indian polyadenylation signal mutation gave an average ratio of wild-type/mutant allele that was closer to 2:1, rather than the ratio expected in a heterozygote of 1:1. These samples were from a father and daughter with normal red cell indices. Gap PCR analysis revealed that both also carried a triplicated α-globin gene on one allele and therefore had a total of five copies of the alpha globin gene, with four genes functioning normally. This explains the observed normal red cell indices and the greater-than-expected ratio of wild-type to mutant allele observed on pyrosequencing.
Discussion
Growing evidence that clinically significant non-deletional α-thalassaemia mutations are present in UK population at significant frequencies has driven the need to develop technologies, which can quickly screen for the most common mutations. Here, we have described the diagnostic utility of pyrosequencing for the rapid detection of ten of the most common non-deletional α-thalassaemia mutations. All mutations selected for screening are clinically important and can result in haemolytic anaemia, Hb H disease or even Hb H hydrops fetalis when homozygous or compound heterozygous with an α 0 -thalassaemia thalassaemia deletion mutation. However, detection of these mutations can be difficult as the α-globin genes reside in GC-rich cluster with high sequence homology, they are also often coinherited with deletional forms of α-thalassaemia which can further complicate diagnosis. Pyrosequencing proved to be very robust and was able to detect all ten mutations in all possible allelic combinations (heterozygotes, homozygous and hemizygous), giving a specific easily interpretable sequencing pattern. As the mutation of interest is detected in the context of its surrounding sequencing, pyrosequencing offers a higher degree of accuracy and therefore potentially has fewer pitfalls than gel-based detection methods. Pyrosequencing also offers the flexibility of positioning the sequencing primer as little as ten base pairs away from the mutation site. This is an advantage when sequencing difficult templates with a high GC content or secondary loop structures (such as the α-globin gene cluster) and is probably the reason that, in our hands, the method proved more robust than Sanger sequencing. In addition, we found the Pyromark Q24 software a useful tool in the rapid analysis of simple mutations, as it assigns an allelic score relative to the normal allele. Allelic quantification represents a distinct advantage of pyrosequencing over conventional Sanger-dideoxy sequencing, which is relatively insensitive and cannot reliably detect mutations when the proportion of mutant to wild-type allele is below 50%. Pyrosequencing, however, has been shown to detect alleles with a frequency as low as 5% [14] . This feature allowed us to distinguish patients carrying an extra copy of the α-globin gene. The Pyromark software has not been designed to detect deletions; as a consequence, samples with the 2 bp Indian polyadenylation signal deletion failed quality assessment; however, visual comparison of the pyrograms with known wild-type controls clearly shows a reduction in peak height of the wild-type nucleotide which allows the mutation to be easily identified. It is therefore very important to include controls to overcome any difficulties in interpretation.
Overall, we felt that pyrosequencing offers a low-cost, rapid method for screening for non-deletion α-thalassaemia mutations. The technique was robust and reliably identified non-deletion alpha thalassaemia even in the presence of coexisting α-globin gene deletions and duplications, a situation which is very common. We also found the method more reliable than Sanger sequencing and good results were obtained even in samples with low or poor quality DNA which had given sub-optimal results on conventional sequencing. Pyrosequencing is rapid in comparison to Sanger sequencing as there are fewer steps which means that results can be obtained in half a day. This reliability and speed means that pyrosequencing would be good method for robust prenatal diagnosis, especially as fetal samples can be of low DNA concentration and fast turnaround times are required. The relatively low cost of the consumables and instrumentation in comparison to Heterozygous for Adana Fig. 2 Pyrograms showing heterozygosity and homozygosity for the α2 globin gene mutation (cd 59 GGC→GAC) that results in the hyper-unstable haemoglobin variant Adana. The Adana assay amplifies all four α-globin genes therefore heterozygosity for α2 Hb Adana results in a 25% reduction in the wild-type allele and homozygosity a 50% reduction in the wild-type allele (sequencing shown is anti-sense) conventional sequencing may also make the method applicable in under-developed countries where haemoglobinopathies are common.
